{"id":"W1978882188","doi":"10.1158/0008-5472.sabcs-09-47","title":"CIRG/TORI 010: 10-Month Analysis of a Randomized Phase II Trial of Motesanib Plus Weekly Paclitaxel as First Line Therapy in HER2-Negative Metastatic Breast Cancer (MBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Placebo; Breast cancer; Gastroenterology; Surgery; Urology; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002915743,0.001867556,0.002492818,0.0005038588,0.000361394,0.001086722,0.001093494,0.001538162,0.006771043],"category_scores_gemma":[0.001978975,0.0008225596,0.001357515,0.0004487922,0.001164311,0.000803938,0.0003739569,0.00335317,0.001397968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001066172,"about_ca_system_score_gemma":0.00122519,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001006123,"about_ca_topic_score_gemma":0.002350249,"domain_scores_codex":[0.9990199,0.0006150003,0.0000400248,0.0001524368,0.00005825674,0.0001144288],"domain_scores_gemma":[0.9988008,0.0002455715,0.0003033138,0.00009025261,0.00005719963,0.0005030188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9696794,0.006529487,0.0009408811,0.0004869696,0.0006822353,0.00006003382,0.0000397409,0.0003167504,0.005323949,0.00005818411,0.001301761,0.01458057],"study_design_scores_gemma":[0.9210245,0.07424699,0.003139796,0.00001570322,0.0004172153,0.00004916525,0.000009256645,0.0002681956,0.0003568406,0.00003302336,0.0004285966,0.00001069999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882103,0.004610105,0.0004459538,0.0007660684,0.0003989782,0.002293192,0.001297891,0.0001950324,0.001782521],"genre_scores_gemma":[0.9884067,0.002036351,0.001073917,0.001004672,0.0005245142,0.002431881,0.002219865,0.00003950413,0.002262511],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006771043,"threshold_uncertainty_score":0.02265143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07820365543155519,"score_gpt":0.4614026070120939,"score_spread":0.3831989515805387,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}